This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Glypican-1 [Cleaved into: Secreted glypican-1]Q9QZF2Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts.
J Cell Physiol. 2007 Feb;210(2):325-35.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
J Proteome Res. 2009 Mar;8(3):1304-14. doi: 10.1021/pr800658c.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
J Proteome Res. 2009 Mar;8(3):1304-14. doi: 10.1021/pr800658c.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Profile of exosomes related proteins released by differentiated and undifferentiated human keratinocytes.
J Cell Physiol. 2009 Oct;221(1):221-31. doi: 10.1002/jcp.21847.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1085-99. doi: 10.1074/mcp.M900381-MCP200. Epub 2010 Feb 1.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Protein profile of exosomes from trabecular meshwork cells.
J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Protein profile of exosomes from trabecular meshwork cells.
J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of microvesicles derived from human colorectal cancer ascites.
Proteomics. 2011 Jul;11(13):2745-51. doi: 10.1002/pmic.201100022. Epub 2011 Jun 1.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625Proteomic analysis of microvesicles derived from human colorectal cancer ascites.
Proteomics. 2011 Jul;11(13):2745-51. doi: 10.1002/pmic.201100022. Epub 2011 Jun 1.
ENOG410XST2239 / 0 / 239
Glypican 4Q642B0Proteolipidic composition of exosomes changes during reticulocyte maturation.
J Biol Chem. 2011 Sep 30;286(39):34426-39. doi: 10.1074/jbc.M111.257444. Epub 2011 Aug 2.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.
Mol Cell Proteomics. 2012 Feb;11(2):M111.012245. doi: 10.1074/mcp.M111.012245. Epub 2011 Oct 26.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410XST2239 / 0 / 239
Glypican 4Q642B0Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies.
Mol Cell Proteomics. 2012 Aug;11(8):230-43. doi: 10.1074/mcp.M111.012732. Epub 2012 Feb 19.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes.
Kidney Int. 2012 Jun;81(12):1263-72. doi: 10.1038/ki.2012.25. Epub 2012 Mar 14.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome.
Int J Proteomics. 2012;2012:971907. doi: 10.1155/2012/971907. Epub 2012 Jul 18.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS.
Mol Cell Proteomics. 2013 Feb;12(2):343-55. doi: 10.1074/mcp.M112.022806. Epub 2012 Nov 15.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]Q9QZF2Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.
Cell. 2012 Dec 21;151(7):1542-56. doi: 10.1016/j.cell.2012.11.024.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Characterization and proteomic analysis of ovarian cancer-derived exosomes.
J Proteomics. 2013 Jan 16;80C:171-182. doi: 10.1016/j.jprot.2012.12.029.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.
Mol Cell Proteomics. 2013 Aug;12(8):2148-59. doi: 10.1074/mcp.M112.027086. Epub 2013 May 3.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition.
Mol Cell Proteomics. 2013 Aug;12(8):2148-59. doi: 10.1074/mcp.M112.027086. Epub 2013 May 3.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression.
PLoS One. 2013 Sep 19;8(9):e75054. doi: 10.1371/journal.pone.0075054. eCollection 2013.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
K-glypicanQ86SV6Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
K-glypicanQ86SV6Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]Q9QZF2Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk?
PLoS One. 2014 Jan 2;9(1):e84153. doi: 10.1371/journal.pone.0084153. eCollection 2014.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]Q9QZF2Proteomic analysis of C2C12 myoblast and myotube exosome-like vesicles: a new paradigm for myoblast-myotube cross talk?
PLoS One. 2014 Jan 2;9(1):e84153. doi: 10.1371/journal.pone.0084153. eCollection 2014.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration.
J Proteome Res. 2014 Feb 7;13(2):581-95. doi: 10.1021/pr400751k. Epub 2014 Jan 16.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon beta-glucan stimulation.
J Proteome Res. 2014 May 2;13(5):2468-77. doi: 10.1021/pr4012552. Epub 2014 Apr 16.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Human urinary exosomes as innate immune effectors.
J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.
ENOG410XST2239 / 0 / 239
Glypican-5 [Cleaved into: Secreted glypican-5]P78333Human urinary exosomes as innate immune effectors.
J Am Soc Nephrol. 2014 Sep;25(9):2017-27. doi: 10.1681/ASN.2013101066. Epub 2014 Apr 3.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Quantitative Proteomic Analysis of Exosome Protein Content Changes Induced by Hepatitis B Virus in Huh-7 Cells Using SILAC Labeling and LC-MS/MS.
J Proteome Res. 2014 Oct 8.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Proteomic analysis of human placental syncytiotrophoblast microvesicles in preeclampsia.
Clin Proteomics. 2014 Nov 19;11(1):40. eCollection 2014.
ENOG410XST2239 / 0 / 239
Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3]P51654Intraluminal proteome and peptidome of human urinary extracellular vesicles.
Proteomics Clin Appl. 2014 Dec 4. doi: 10.1002/prca.201400085.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]Q9QZF2Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel.
Oncotarget. 2015 Mar 12.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]B4E2C0Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Methods. 2015 Apr 16. pii: S1046-2023(15)00154-1. doi: 10.1016/j.ymeth.2015.04.008.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]B4E2C0Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Methods. 2015 Apr 16. pii: S1046-2023(15)00154-1. doi: 10.1016/j.ymeth.2015.04.008.
ENOG410XST2239 / 0 / 239
Glypican-6 [Cleaved into: Secreted glypican-6]Q9Y625Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes.
Oncotarget. 2015 Apr 12.
ENOG410XST2239 / 0 / 239
Glypican-2 [Cleaved into: Secreted glypican-2]Q8N158Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes.
Oncotarget. 2015 Apr 12.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]Q9QZF2Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410XST2239 / 0 / 239
Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4]O75487Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410XST2239 / 0 / 239
Glypican-1 [Cleaved into: Secreted glypican-1]P35052Ionizing radiation affects protein composition of exosomes secreted in vitro from head and neck squamous cell carcinoma.
Acta Biochim Pol. 2015;62(2):265-72. doi: 10.18388/abp.2015_970. Epub 2015 Jun 22.
ENOG410XST2239 / 0 / 239
[1] [2] [3] [4] [5]